Liposomes and nanotechnology in drug development: focus on ocular targets
about
Novel Strategies for the Improvement of Stem Cells' Transplantation in Degenerative Retinal DiseasesLipid Nanoparticles for Ocular Gene DeliveryOptimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularizationOral absorption enhancement of probucol by PEGylated G5 PAMAM dendrimer modified nanoliposomesEfficacy and safety of dendrimer nanoparticles with coexpression of tumor necrosis factor-α and herpes simplex virus thymidine kinase in gene radiotherapy of the human uveal melanoma OCM-1 cell line.Drug delivery techniques for treating age-related macular degeneration.Nanodrugs: pharmacokinetics and safety.Topical delivery of ocular therapeutics: carrier systems and physical methods.Colloidal drug delivery system: amplify the ocular delivery.Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs.Nanocrystal for ocular drug delivery: hope or hype.Lipid-based drug delivery systems in the treatment of wet age-related macular degeneration.Current advances in the treatment of neovascular age-related macular degeneration.Nanoparticles for the delivery of therapeutic antibodies: Dogma or promising strategy?High Throughput Screening of Valganciclovir in Acidic Microenvironments of Polyester Thin Films.Mechanism of the anticataract effect of liposomal MgT in galactose-fed rats.Dorzolamide Loaded Niosomal Vesicles: Comparison of Passive and Remote Loading Methods.Diclofenac sodium ion exchange resin complex loaded melt cast films for sustained release ocular delivery.[Nanoparticles as drug delivery systems in ophthalmology].How can nanoparticles be used to overcome the challenges of glaucoma treatment?Preparation and ocular pharmacokinetics of hyaluronan acid-modified mucoadhesive liposomes.
P2860
Q26746982-1B1559D3-2571-4379-80A4-0B78F06FFCCEQ26823895-BC460336-3350-46C9-9750-D0F31907658AQ34571360-EACA0810-9F53-44F6-8F11-22DBB9FB2A02Q35224472-02EDF430-FE01-465B-9C6F-CD78E195EB49Q36628814-25059807-E173-4200-BFF7-EDC379BAF7E1Q37225620-6E17F8CD-29EA-467F-9923-7AAA97355032Q38161953-22FCC6BB-77D4-428A-B119-9B08800870F1Q38193067-6691F0AD-51BC-4BE5-89EB-C8FE85B24428Q38196446-76F8A2EB-D2EC-424E-B29F-E15A7BA4F076Q38217270-4F9264B2-74A9-4C81-8021-7115C140E887Q38406190-86D41B2D-51E2-4337-AB33-847DC8123911Q38831205-3069DAEC-EEC1-4D9E-8E3A-F5144A5D4968Q38837906-6E8BECAE-72CB-49E7-A569-BF88973F97B4Q38902191-883EEE8C-27E4-44CC-978D-5BF60D528D22Q39049314-1060E4C7-532F-48A5-A6CE-D5438D15A513Q40992924-54B4F076-2F21-425F-993C-B0ACCEC9AF6DQ41985198-B8687339-49B7-41EA-94E5-B474338007FEQ42360534-8E1F5FB5-E5B3-4599-A9B9-79E3634FC2AEQ47444145-174EC461-8038-4A54-801C-EEB9C411C0CEQ50129671-347E6F03-95A4-4B2A-BED5-2A85E9EE95A0Q53451278-9A3FD2FB-FAD3-4901-AB6D-7FC564F59237Q53655341-4C0A5B2E-C0D0-4B1D-9491-385075D344AB
P2860
Liposomes and nanotechnology in drug development: focus on ocular targets
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Liposomes and nanotechnology in drug development: focus on ocular targets
@ast
Liposomes and nanotechnology in drug development: focus on ocular targets
@en
Liposomes and nanotechnology in drug development: focus on ocular targets.
@nl
type
label
Liposomes and nanotechnology in drug development: focus on ocular targets
@ast
Liposomes and nanotechnology in drug development: focus on ocular targets
@en
Liposomes and nanotechnology in drug development: focus on ocular targets.
@nl
prefLabel
Liposomes and nanotechnology in drug development: focus on ocular targets
@ast
Liposomes and nanotechnology in drug development: focus on ocular targets
@en
Liposomes and nanotechnology in drug development: focus on ocular targets.
@nl
P2093
P2860
P921
P3181
P356
P1476
Liposomes and nanotechnology in drug development: focus on ocular targets
@en
P2093
P2860
P304
P3181
P356
10.2147/IJN.S30725
P407
P577
2013-01-01T00:00:00Z
2013-02-14T00:00:00Z